Synthetic human IL-1B is rapidly becoming the critical resource for investigators in several fields. The carefully manufactured version of interleukin-1 beta offers advantages over naturally occurring IL-1B, including improved quality and reliable activity. Investigators are employing it to more effectively investigate a role of IL-1B in complicate